April 26, 2022
Shionogi’s oral COVID-19 treatment S-217622 improved respiratory and feverish symptoms associated with the disease as compared to placebo, according to new data released by the company. The Osaka drug maker said that S-217622 showed no statistically significant difference versus placebo...read more